|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Chronic sinusitis | 12-Jan-2024 | active |
| Prediabetes | 07-Feb-2019 | active |
| Osteoarthritis of knee | 13-Dec-2015 | active |
| Dependent drug abuse | 23-Sep-1994 | active |
| Impacted molars | 30-Jun-1991 | active |
| Chronic intractable migraine without aura | 19-Mar-1990 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Naproxen sodium 220 mg oral capsule | 2015-12-13 | - | 1 tablet (220 mg) by mouth every 12 hours as needed | Osteoarthritis of knee |
Immunizations list
| Vaccine | Date |
|---|---|
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 13-Mar-2025 |
| Influenza virus antigen only vaccine product | 13-Mar-2025 |
| SARS-CoV-2 mRNA vaccine | 20-May-2021 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 26-Oct-2023 | - |
| Medication reconciliation | 26-Oct-2023 | - |
| Assessment of health and social care needs | 26-Oct-2023 | - |
| Assessment of anxiety | 26-Oct-2023 | - |
| Screening for domestic abuse | 26-Oct-2023 | - |
| Depression screening using Patient Health Questionnaire Two-Item score (procedure) | 26-Oct-2023 | - |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| ? | active | ? |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Diabetes self management plan | 07-Feb-2019 | Prediabetes |
|
||
| Musculoskeletal care | 13-Dec-2015 | Osteoarthritis of knee |
|
||
| Care plan | 27-Mar-1999 | - |
| Immunization Recommendation | Due Date | Reason |
| Vaccine product containing only Influenza virus antigen (medicinal product) | 01-Oct-2025 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2025-03-13 | 2024-03-07 |
|---|---|---|
| Body Height | 156.3 cm | 156.3 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 {score} | 1 {score} |
| Body Weight | 72.6 kg | 70.9 kg |
| Body mass index (BMI) [Ratio] | 29.7 kg/m2 | 29 kg/m2 |
| Diastolic Blood Pressure | 69 mm[Hg] | 67 mm[Hg] |
| Systolic Blood Pressure | 119 mm[Hg] | 116 mm[Hg] |
| Heart rate | 74 /min | 70 /min |
| Respiratory rate | 15 /min | 13 /min |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 13-MAR-2025 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | 4 - 6 | % |
| Glucose [Mass/volume] in Blood | 85.2 | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 7.2 | 7 - 25 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.7 | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 8.9 | 8.5 - 10.4 | mg/dL |
| Sodium [Moles/volume] in Blood | 141.7 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 3.9 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 103.1 | 98 - 108 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 28.9 | 22 - 29 | mmol/L |
Device Use
| Device | Date (since) |
|---|---|
| Home nebulizer (physical object) | 12-Jan-2024 |
| Blood glucose meter (physical object) | 07-Feb-2019 |
| Walker (physical object) | 13-Dec-2015 |